Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tibetan medicine advanced over past decade 2023-04-24 17:04
Daewoong Pharmaceutical Announce Publication of Phase 3 Study of 'Envlo', a New Treatment for Diabetes, in the International SCIE Journal 2023-04-24 14:53
Samsung Biologics Reports First Quarter 2023 Financial Results 2023-04-24 14:51
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901 2023-04-24 10:23
SCG Cell Therapy to Present Late-Breaking Data at the International Society for Cell & Gene Therapy (ISCT) Highlighting Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma 2023-04-24 10:00
Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform 2023-04-24 08:00
Everest Medicines Launches Nefecon in China's Hainan Boao Pilot Zone as a First-in-Disease Therapy for IgA Nephropathy 2023-04-24 07:44
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer 2023-04-21 09:06
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business 2023-04-21 00:00
CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer 2023-04-20 20:50
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics 2023-04-20 20:30
BioMed Technology Funded by Alibaba Hong Kong Entrepreneurs Fund, Gobi and TIMC to Realise Precision and Personalised Gut Microbiome Management for Wellness 2023-04-20 16:15
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
500 women join Australia's landmark maternity medical device study 2023-04-19 21:08
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability 2023-04-19 21:00
China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering 2023-04-19 20:30
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line 2023-04-19 20:05
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use 2023-04-19 11:05
AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting 2023-04-19 08:29
1 73 74 75 76 77 377